Compound Ammonium Glycyrrhetate Injection

Compound Ammonium Glycyrrhetate Injection, produced to Chinese Pharmacopoeia (ChP) standards, is indicated for abnormal liver function arising from acute and chronic hepatitis, with auxiliary use in toxic hepatitis, food poisoning, drug poisoning, and drug allergy. Hebei Tiancheng Pharmaceutical Co., Ltd. supplies the product as a trading company rather than the manufacturer, marketing it across Central/South America, Eastern Europe, Asia, the Middle East, and Africa; samples are not offered.